The Saint Louis team, led by Susan Farr, PhD, a professor of geriatrics at the university, developed a compound called antisense oligonucleotide (OL-1). When tested on mouse models with Alzheimer's disease, they found the compound reversed classic symptoms of the disease - brain inflammationand learning and memory deficits.
This is the latest in a line of studies to look into potential treatments for Alzheimer's. Medical News Todayrecently reported on a study published in Nature Chemical Biology, which suggested that a novel class of compounds called "pharmacologic chaperones" could significantly reduce amyloid-beta levels in Alzheimer's patients.
Recent research from Ohio State University found that caring for horses may ease symptoms of Alzheimer's, while a study from the Washington University School of Medicine in St. Louis, MO, and the University of Pennsylvania suggested that Alzheimer's onset could be slowed with a commonly prescribed antidepressant.